The editors roundtable: Implantable cardioverter-defibrillators in primary prevention of sudden cardiac death and disparity-related barriers to implementation

American Journal of Cardiology

Volumn 107, Issue 4, 2011, Pages 583-590

  Friedewald, Vincent E ^a,b   Fonarow, Gregg C ^c   Olshansky, Brian ^d,e   Yancy, Clyde W ^e   Roberts, William C ^d,e,f  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA   (United States)

^e BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^f BAYLOR HEALTH CARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTINUING EDUCATION; CULTURAL FACTOR; DEFIBRILLATOR; HEART DEATH; HUMAN; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; SUDDEN DEATH; TREATMENT INDICATION; ARTICLE; HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; MEDICAL EDUCATION; METHODOLOGY; ORGANIZATION AND MANAGEMENT; RISK ASSESSMENT; RISK FACTOR; TREATMENT OUTCOME;

ANTIARRHYTHMIC AGENT;

ANTI-ARRHYTHMIA AGENTS; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; EDUCATION, MEDICAL, CONTINUING; HEART FAILURE; HUMANS; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 79551671241     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.10.003     Document Type: Note

References (7)

1. M. Mirowski, P.R. Reid, M.M. Mower, L. Watkins, V.L. Gott, J.F. Schauble, A. Langer, M.S. Heilman, S.A. Kolenik, R.D. Frischell, and M.L. Weisfeldt Termination of malignant ventricular arrhythmias with an implantable automatic defibrillator in human beings N Engl J Med 303 1980 322 324
2. M. Mirowski, M.M. Mower, A. Langer, M.S. Heilman, and L. Schreibman A chronically implanted system for automatic defibrillation in active conscious dogs: experimental model for treatment of sudden death from ventricular fibrillation Circulation 58 1978 90 94
3. A.E. Epstein, J.P. DiMarco, K.A. Ellenbogen, N.A.M. Estes, R.A. Freedman, L.S. Gettes, A.M. Gillinov, G. Gregoratos, S.C. Hammill, D.L. Hayes, M.A. Hlatky, L.K. Newby, R.L. Page, M.H. Schonfeld, M.J. Sitka, L.W. Stevenson, and M.O. Sweeny ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: executive summary Circulation 117 2008 2820 2840
4. S.H. Hohnloser, K.H. Kuck, P. Dorian, R.S. Roberts, J.R. Hampton, R. Hatala, E. Fain, M. Gent, S.J. Connolly DINAMIT Investigators Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction N Engl J Med 351 2004 2481 2488
5. G.C. Fonarow, C.W. Yancy, N.M. Albert, A.B. Curtis, W. Gattis Stough, M. Gheorghiade, J.T. Heywood, M. Mehra, C.M. OConnor, D. Reynolds, and N.M. Walsh Improving the use of evidence-based heart failure therapies in the outpatient setting: the IMPROVE HF performance improvement registry Am Heart J 154 2007 12 38
6. G.H. Bardy, K.L. Lee, D.B. Mark, J.E. Poole, D.L. Packer, R. Boineau, M. Domanski, C. Troutman, J. Anderson, G. Johnson, S.E. McNulty, N. Clapp-Channing, L.D. Davidson, E.S. Fraulo, D.P. Fishbein, R.M. Luceri, J.H. Ip Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure N Engl J Med 352 2005 225 237
7. A.F. Hernandez, G.C. Fonarow, L. Liang, S.M. AI-Khatib, L.H. Curtis, K.A. LaBresh, C.W. Yancy, N.M. Albert, and E.D. Peterson Sex and racial differences in the use of implantable cardioverter-defibrillators among patients hospitalized with heart failure JAMA 298 2007 1525 1532